The COVID-19 pandemic saw the pharma landscape change drastically. With an end seemingly now in sight, experts are looking towards the future of the industry.
In this article, our chief commercial officer, Tony O’Sullivan, talks to Pharma Manufacturing about the top pharmaceutical industry trends for 2021, namely a significant growth in the high-potency active pharmaceutical ingredient (HPAPI) manufacturing space, where the market is set to grow to $33 billion by 2025. With these ingredients providing increased effectiveness and a reduction in required dosage while still achieving the same impact, more contract service providers will be expanding their HPAPI manufacturing capacity to meet increased customer demand.
The full article can be found HERE
